Generic placeholder image

Current Drug Discovery Technologies


ISSN (Print): 1570-1638
ISSN (Online): 1875-6220

Potent Phosphatidylinositol 3-Kinase Inhibitors and Their Biology

Author(s): Mukesh Chandra Joshi, Krishan Kumar and Vikrant Kumar

Volume 11, Issue 2, 2014

Page: [113 - 126] Pages: 14

DOI: 10.2174/1570163810666131229130207

Price: $65


The Phosphoinositide 3-kinase (PI3k) is an important regulator of intracellular signalling pathways, like cell proliferation, migration, survival, and angiogenesis upon activation by growth factor or receptors. The PI3k’s pathway is frequently up-regulated in human cancers, thus inhibition of PI3k’s is a promising approach for cancer therapy. Many potent PI3k’s inhibitors have been reported so far and few of them are in clinical trial like GDC-0941, BGT-226, AZD-6482 and others are natural products etc.

Keywords: Clinical trial, glioblastoma cell lines, leukemia and lymphoma cell lines, phosphoinositide 3-kinase, proliferation, tumor inhibitors.

Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy